Ex vivo-expanded human CD19

Animals Antigens, CD19 / metabolism B-Lymphocytes, Regulatory Carcinoma, Squamous Cell / metabolism Humans Interleukin-10 / metabolism Lymphocyte Activation Mice STAT3 Transcription Factor / metabolism Skin Neoplasms / metabolism

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
03 06 2022
Historique:
received: 05 04 2017
accepted: 05 05 2022
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 9 6 2022
Statut: epublish

Résumé

Regulatory B cells (Breg) are a heterogenous population with immune-modulating functions. The rarity of human IL-10

Identifiants

DOI: 10.1038/s41467-022-30613-z PMID: 35660734 PMC: PMC9166804
pubmed: 35660734
doi: 10.1038/s41467-022-30613-z
pii: 10.1038/s41467-022-30613-z
pmc: PMC9166804
doi:

Substances chimiques

Antigens, CD19 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3121

Subventions

Organisme : Wellcome Trust
ID : HJRWQJ00
Pays : United Kingdom
Organisme : Department of Health
ID : RCF20/055
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 097932/Z/11/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : ISSF0007267
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211122/Z/18/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

J Immunol. 2011 May 15;186(10):5569-79
pubmed: 21464089
Int J Cancer. 2016 Sep 15;139(6):1358-71
pubmed: 27130719
Cancer Cell. 2014 Jun 16;25(6):809-821
pubmed: 24909985
PLoS One. 2013 May 29;8(5):e64159
pubmed: 23734190
Am J Transplant. 2015 Apr;15(4):942-53
pubmed: 25645598
Sci Transl Med. 2021 Feb 24;13(582):
pubmed: 33627487
Nat Med. 2010 Jul;16(7):809-13
pubmed: 20473306
Transplantation. 2010 Dec 27;90(12):1321-7
pubmed: 21048528
PLoS One. 2012;7(12):e53331
pubmed: 23300911
Nat Commun. 2021 Mar 9;12(1):1534
pubmed: 33750787
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10772-6
pubmed: 7479881
Immunology. 2005 Dec;116(4):454-63
pubmed: 16313359
Cancer Cell. 2005 May;7(5):411-23
pubmed: 15894262
J Autoimmun. 2011 May;36(3-4):228-38
pubmed: 21316922
J Immunol. 2010 May 1;184(9):4801-9
pubmed: 20368271
Brief Funct Genomics. 2013 Nov;12(6):489-98
pubmed: 23943603
J Biol Chem. 1998 Nov 20;273(47):31222-9
pubmed: 9813029
Blood. 2015 Mar 12;125(11):1830-9
pubmed: 25605369
J Clin Invest. 2010 Jun;120(6):1836-47
pubmed: 20501946
Sci Rep. 2020 Oct 1;10(1):16188
pubmed: 33004854
J Immunol. 2009 Mar 15;182(6):3492-3502
pubmed: 19265127
Arthritis Res Ther. 2017 Jan 19;19(1):8
pubmed: 28103916
Arch Immunol Ther Exp (Warsz). 2011 Feb;59(1):25-40
pubmed: 21234809
Blood. 2007 May 15;109(10):4135-42
pubmed: 17234735
Blood. 2011 Jan 13;117(2):530-41
pubmed: 20962324
Eur J Immunol. 2014 Jun;44(6):1728-36
pubmed: 24700192
Immunity. 2010 Jan 29;32(1):129-40
pubmed: 20079667
Nature. 2015 May 7;521(7550):94-8
pubmed: 25924065
Immunity. 2015 Apr 21;42(4):607-12
pubmed: 25902480
Nat Med. 2014 Jun;20(6):633-41
pubmed: 24743305
J Am Soc Nephrol. 2014 Jan;25(1):105-18
pubmed: 24158981
Cancer Cell. 2010 Feb 17;17(2):121-34
pubmed: 20138013
Commun Biol. 2020 Jul 14;3(1):375
pubmed: 32665635
Mol Med. 2012 Jul 18;18:733-43
pubmed: 22252714
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12105-10
pubmed: 22773818
J Clin Invest. 2011 Sep;121(9):3645-56
pubmed: 21821911
Arthritis Res Ther. 2012 Feb 08;14(1):R32
pubmed: 22315945
J Exp Med. 2003 Feb 17;197(4):489-501
pubmed: 12591906
Nature. 2012 Nov 8;491(7423):264-8
pubmed: 23064231
Nature. 2014 Mar 20;507(7492):366-370
pubmed: 24572363
J Immunol. 2017 Feb 15;198(4):1512-1520
pubmed: 28087671
Cancer Immunol Immunother. 2011 May;60(5):609-19
pubmed: 21253724
J Immunol. 2019 Oct 15;203(8):2110-2120
pubmed: 31511354
Sci Rep. 2018 Aug 14;8(1):12144
pubmed: 30108345
Nat Med. 2014 Nov;20(11):1334-9
pubmed: 25326801
J Immunol. 2016 Sep 15;197(6):2316-24
pubmed: 27534560
Semin Immunol. 1994 Oct;6(5):267-78
pubmed: 7532457
Am J Transplant. 2016 Dec;16(12):3443-3457
pubmed: 27328267
PLoS One. 2014 Feb 21;9(2):e89236
pubmed: 24586620
Sci Transl Med. 2013 Feb 20;5(173):173ra23
pubmed: 23427243
J Immunol. 2011 Feb 15;186(4):2643-54
pubmed: 21248259
J Clin Invest. 2010 Jun;120(6):1848-61
pubmed: 20501943
J Allergy Clin Immunol. 2013 Apr;131(4):1204-12
pubmed: 23453135
Nat Med. 2000 Jun;6(6):673-9
pubmed: 10835684
J Immunol. 2007 Jun 15;178(12):7868-78
pubmed: 17548625
Immunity. 2008 May;28(5):639-50
pubmed: 18482568
J Immunol. 2015 Feb 15;194(4):1602-8
pubmed: 25582854

Auteurs

S Shankar (S)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. sushma.shankar@nds.ox.ac.uk.
Oxford Transplant Centre, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. sushma.shankar@nds.ox.ac.uk.
ORCID: 0000-0002-9843-6245

J Stolp (J)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

S C Juvet (SC)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
ORCID: 0000-0002-7243-556X

J Beckett (J)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

P S Macklin (PS)

Nuffield Department of Medicine Research Building, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

F Issa (F)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
ORCID: 0000-0002-8279-7732

J Hester (J)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
ORCID: 0000-0002-7466-3849

K J Wood (KJ)

Translational Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. kathryn.wood@nds.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Ex vivo-expanded human CD19
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes B › Antigènes CD19 › Ex vivo-expanded human CD19
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes B › Sous-populations de lymphocytes B › Lymphocytes B régulateurs › Ex vivo-expanded human CD19
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs épidermoïdes › Carcinome épidermoïde › Ex vivo-expanded human CD19
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Ex vivo-expanded human CD19
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-10 › Ex vivo-expanded human CD19
questionsmedicales.fr › Phénomènes du système immunitaire › Activation des lymphocytes › Ex vivo-expanded human CD19
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Ex vivo-expanded human CD19
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription STAT › Facteur de transcription STAT-3 › Ex vivo-expanded human CD19
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › Ex vivo-expanded human CD19